These investments will help Ohio law enforcement secure critical tools and equipment to keep communities safe, as well as enhance access to prevention, treatment, and recovery services for individuals with substance abuse disorders.
read more
Over the past decade, the illicit drug trade primarily developed and used fentanyl analogs.
read more
New research suggests that in Oregon and Washington, two states that implemented drug decriminalization policies in early 2021, there is no evidence of an association between decriminalization and fatal drug overdose rates.
read more
At issue are post-overdose outreach programs, which are designed to reach out to people who have recently survived an overdose.
read more
New research out of UCLA shows the proportion of overdose deaths in the U.S. involving both fentanyl and stimulants has increased more than 50-fold since 2010—from 0.6% (235 deaths) in 2010 to 32.3% (34,429 deaths) in 2021.
read more
Emanuele Alves is developing a device that could offer results within minutes and reduce false positives.
read more
Recently acquired in vitro pharmacological data shows this emergent novel synthetic opioid—called N-pyrrolidino protonitazene (also protonitazepyne)—is 25x more potent than fentanyl.
read more
Annual rates of emergency department visits for cannabis-involved traffic injury increased by 475 percent over 13 years, according to a new study from The Ottawa Hospital.
read more
In January, the CFSRE will move into a new state of the art facility in suburban Philadelphia that will
accommodate the growing scope and scale of its mission to educate, train and conduct research.
read more
Scientists gave an experimental insomnia treatment to rats experiencing oxycodone withdrawal. The researchers found that the animals were far less likely to seek out drugs again in the future—even after ending the treatment.
read more
Alabama State University’s world-renowned expert on forensic-death studies, Gulnaz Javan, has received a $375,000 grant from the National Institute of Health to help fight the scourge of drug-related deaths by studying microbiomes in deaths caused by cocaine overdose.
read more
The Food and Drug Administration (FDA) has selected the LightLab 3 High Sensitivity (HS) Cannabis Analyzer to play a pivotal role in its efforts to regulate the national cannabis industry.
read more
Research suggests that the attention-deficit/hyperactivity disorder drug methylphenidate (MPH; Ritalin) could serve as a cocaine-replacement therapy, but clinical results have been mixed.
read more
Kentucky’s 2007 lawsuit against Purdue Pharma marked a major turn in the opioid crisis. But a new study finds that the case dissuaded only Purdue’s opioid marketing. Promotion of opioids by competing drug companies actually increased.
read more
On Friday, the U.S. Food and Drug Administration approved RiVive, 3 milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use for the emergency treatment of known or suspected opioid overdose.
read more